Novigenix is a pioneering, precision medicine biotech, focusing on AI-RNA analysis to improve treatment outcomes for cancer patients. Our immuno- transcriptomic solutions make earlier detection of disease possible, capture the immune profile of the patient in order to predict likely response to treatment, and enable novel drug development.
The Novigenix platform is optimized for whole-blood RNA biomarkers, and mapping of the patient’s immune system response to disease and treatment. The platform integrates patient multi-modal data and leverages advanced artificial intelligence approaches to provide actionable insights and precision solutions for the optimization of the patient ́s therapeutic journey.
Through our technology we offer:
- Early detection of disease
- Patient immune system response monitoring
- Capture of the immune profile to predict immune system response totreatment
- Enabling of biomarker development and drug-target discovery
Novigenix is the leading partner of choice for Pharma and Biotech wanting to leverage AI-RNA analytics to generate previously unknown insights into patient disease states and response to treatment.
